Wednesday, August 29, 2012

Health - Google News: Lilly ends studies of new schizophrenia drug - Businessweek

Health - Google News
Google News
Lilly ends studies of new schizophrenia drug - Businessweek
Aug 29th 2012, 15:33


Inside INdiana Business

Lilly ends studies of new schizophrenia drug
Businessweek
INDIANAPOLIS (AP) — Eli Lilly and Co. said Wednesday it is ending studies of an experimental schizophrenia drug based on negative clinical trial results. Lilly said an analysis showed a late-stage study of pomaglumetad methionil indicated the drug was ...
Lilly halts development of schizophrenia drugMarketWatch
Lilly Ends Development of Schizophrenia DrugWall Street Journal
Eli Lilly to stop developing schizophrenia drugReuters
Bloomberg -FierceBiotech
all 68 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

0 comments:

Post a Comment

Twitter Delicious Facebook Digg Stumbleupon Favorites More